Lumacaftor: used for the treatment of cystic fibrosis in patients that present the F508del in the CFTR (cystic fibrosis transmembrane conductance regulator) protein[15]; IC50 of 84 ± 4 μM toward the S protein. Here, CFTR is linked to cystic fibrosis.